• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BIO-TECHNOLOGY GENERAL (ISRAEL) LTD. EUFLEXXA; 1%  SODIUM HYALURONATE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BIO-TECHNOLOGY GENERAL (ISRAEL) LTD. EUFLEXXA; 1%  SODIUM HYALURONATE Back to Search Results
Catalog Number 6301182010
Device Problem Lack of Effect (4065)
Patient Problem Aneurysm (1708)
Event Type  Injury  
Event Description
Two aneurysms [aneurysm].Has been on euflexxa before but it did not work [device ineffective].Case narrative: case (b)(4) is a serious complaint spontaneous case received from a non health professional fda from us.This report concerns a female patient of unknown age, who experienced two aneurysms and that euflexxa did not work during treatment with intra-articular euflexxa (sodium hyaluronate) solution for injection unknown concentration and dose, for unknown indication from an unknown start date and unknown if ongoing.The patient had been on euflexxa before, but it did not work, and the patient had to have a knee replacement on an unspecified date in 2018.The patient was hospitalized for having two aneurysms on an unknown date in 2019.No additional information was provided.Action taken with euflexxa was unknown.At the time of this report, the outcome of two aneurysms and did not work was unknown.The following concomitant medications were reported: carafate, protonix, duloxetine, amlodipine, zolpidem, triamterene hctz, esomeprazole magnesium, montelukast, buspirone, benazepril , keppra and atorvastatin.The event two aneurysms was reported as serious.The event did not work was reported as non-serious.At the time of reporting the case outcome was unknown.Overall listedness (core label) is unlisted.Reporter causality: related.Company causality: not related.Other case numbers: internal # - others = mw5089080; internal # - complaint = (b)(4); internal # - affiliate = (b)(4).This ae occurred in united states and concerns the medical device euflexxa.Please report to your local health authority if required by local law.This ae is not reportable in eu because it does not meet the definition of a medical device incident according to the requirements of the medical device directive/ because it did not occur in a eu + efta country and did not result in a corrective action by the manufacturer.No corrective action was done by the manufacturer or requested by regulators.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
EUFLEXXA
Type of Device
1%  SODIUM HYALURONATE
Manufacturer (Section D)
BIO-TECHNOLOGY GENERAL (ISRAEL) LTD.
pob 571, be'er tuvia industria
l zone
kiryat malachi 83104 02
IS  8310402
MDR Report Key16438953
MDR Text Key310228944
Report Number0002244564-2019-00040
Device Sequence Number1
Product Code MOZ
Combination Product (y/n)Y
Reporter Country CodeUS
Number of Events Reported1
Summary Report (Y/N)N
Report Source Distributor
Reporter Occupation Non-Healthcare Professional
Type of Report Initial
Report Date 02/22/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received02/24/2023
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Catalogue Number6301182010
Was Device Available for Evaluation? No
Was the Report Sent to FDA? No
Event Location Other
Type of Device Usage A
Patient Sequence Number1
Treatment
AMLODIPINE (AMLODIPINE),; ATORVASTATIN (ATORVASTATIN),; BENAZEPRIL (BENAZEPRIL),; BUSPIRONE (BUSPIRONE),; CARAFATE (SUCRALFATE),; DULOXETINE (DULOXETINE),; ESOMEPRAZOLE MAGNESIUM (ESOMEPRAZOLE MAGNESIUM),; KEPPRA (LEVETIRACETAM),; MONTELUKAST (MONTELUKAST),; PROTONIX /00661201/ (OME; TRIAMTERENE HCTZ (HYDROCHLOROTHIAZIDE, TRIAMTERENE; ZOLPIDEM (ZOLPIDEM),
Patient Outcome(s) Hospitalization;
Patient SexFemale
-
-